Latest News About Antidepressants Recall

Here’s the latest recall news I can share now:

• UK MHRA precautionary recall (April 27, 2026): Sertraline 100 mg batch recall and stock return advised for ongoing supply chains. This is a safety measure tied to a manufacturing issue, not a patient-level adverse event report. If you or someone you know uses sertraline, check with your pharmacist or prescriber about batch numbers and guidance. [source: GOV.UK briefing, MHRA notice]

• Earlier recalls of antidepressants (2024–2025): There have been multiple recalls involving duloxetine (Cymbalta) and other antidepressants due to issues like dissolution performance or potential contaminants, with the U.S. FDA classifying some recalls as Class II (temporary or reversible health effects) and others as precautionary due to manufacturing or stability concerns. If you’re affected, contact your pharmacy or healthcare provider for a replacement or alternative and avoid using recalled lots. [sources include FDA-sourced recall notices and industry reports]

• Consumer-facing guidance during recalls: For any recalled antidepressant, you should:

  • Do not stop a prescribed antidepressant abruptly; consult your clinician for a safe plan.
  • Check the lot/batch numbers on the bottle and compare with recall notices.
  • Return affected lots per the instructions provided, and seek a replacement or alternative if advised.

Important caveat: Recall headlines can be highly location- and batch-specific (country, manufacturer, dosage form). To ensure you get the exact, current status for your medication, please share your country and the exact drug name, dosage, and the lot number or expiration date. I can then look up the precise, locally applicable recall details and next steps. If you’d like, I can also help you contact your pharmacist or clinician to verify your particular lot and arrange a safe course of action.